Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Recommended Immunization Schedules for Adults

United States, 2017

For Healthcare Professionals

Each year, the Advisory Committee on Immunization Practices (ACIP) approves immunization schedules recommended for persons living in the United States. The adult immunization schedule provides a summary of ACIP recommendations on the use of licensed vaccines routinely recommended for adults aged 19 years or older. The adult immunization schedule is also approved by the American College of Physicians (ACP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG), and the American College of Nurse-Midwives (ACNM).


2017 Immunization Schedules

In October 2016, ACIP approved the 2017 Immunization Schedule for Adults aged 19 years or older, effective February 1, 2017.

The comprehensive summary of the ACIP recommended changes made to the adult immunization schedule can be found in the MMWR.

Changes to the schedule include:

Influenza

  • LAIV should not be used during the 2016–2017 influenza season.
  • Adults with a history of egg allergy who have only hives after exposure to egg should receive age-appropriate inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV).
  • Adults with a history of egg allergy with symptoms other than hives (e.g., angioedema, respiratory distress, lightheadedness, or recurrent emesis, or who required epinephrine or another emergency medical intervention) may receive age-appropriate IIV or RIV. The selected vaccine should be administered in an inpatient or outpatient medical setting and supervised by a health care provider who is able to recognize and manage severe allergic conditions.

Hep B

  • Adults with chronic liver disease, including, but not limited to, hepatitis C virus infection, cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, and an alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level greater than twice the upper limit of normal should receive a HepB series.

HPV

  • Adult females through age 26 years and adult males through age 21 years who have not received any HPV vaccine should receive a 3-dose series of HPV vaccine at 0, 1–2, and 6 months. Males aged 22 through 26 years may be vaccinated with a 3-dose series of HPV vaccine at 0, 1–2, and 6 months.
  • Adult females through age 26 years and adult males through age 21 years (and males aged 22 through 26 years who may receive HPV vaccine) who initiated HPV vaccination series before age 15 years and received 2 doses at least 5 months apart are considered adequately vaccinated and do not need an additional dose of HPV vaccine.
  • Adult females through age 26 years and adult males through age 21 years (and males aged 22 through 26 years who may receive HPV vaccine) who initiated HPV vaccination series before age 15 years and received only 1 dose, or 2 doses less than 5 months apart, are not considered adequately vaccinated and should receive 1 additional dose of HPV vaccine.

Meningococcal Disease

  • Adults with anatomical or functional asplenia or persistent complement component deficiencies should receive a 2-dose primary series of MenACWY, with doses administered at least 2 months apart, and revaccinate every 5 years. They should also receive a series of MenB with either MenB-4C (2 doses administered at least 1 month apart) or MenB-FHbp (3 doses administered at 0, 1–2, and 6 months).
  • Adults with HIV infection who have not been previously vaccinated should receive a 2-dose primary MenACWY vaccination series, with doses administered at least 2 months apart, and be revaccinated every 5 years. Those who previously received 1 dose of MenACWY should receive a second dose at least 2 months after the first dose. MenB is not routinely recommended for adults with HIV infection, because meningococcal disease in this population is caused primarily by serogroups C, W, and Y.
  • Microbiologists who are routinely exposed to isolates of Neisseria meningitidis should receive 1 dose of MenACWY and be revaccinated every 5 years if the risk for infection remains, as well as either MenB-4C (2 doses administered at least 1 month apart) or MenB-FHbp (3 doses administered at 0, 1–2, and 6 months).
  • Adults at risk because of a meningococcal disease outbreak should receive 1 dose of MenACWY if the outbreak is attributable to serogroup A, C, W, or Y; or, if the outbreak is attributable to serogroup B, either MenB-4C (2 doses administered at least 1 month apart) or MenB-FHbp (3 doses administered at 0, 1–2, and 6 months).
  • Young adults aged 16 through 23 years (preferred age range is 16 through 18 years) who are healthy and not at increased risk for serogroup B meningococcal disease may receive either a 2-dose series of MenB-4C at least 1 month apart or a 2-dose series of MenB-FHbp at 0 and 6 months for short-term protection against most strains of serogroup B meningococcal disease.

View or Print Schedules

Adult schedule

Adult Immunization Schedule, Full Version


Adult Schedule, by Vaccine and Age Group

Adult Immunization Schedule, by Vaccine and Age Group

Display and print the adult schedule, by vaccine and age group.


Medical Indications Schedule

Adult Immunization Schedule by Medical and Other Indications

Display and print the adult immunization schedule based on medical and other indications.


Contraindications and Precautions

Top of Page

Laminated Pocket-size Schedules

Adult Immunization Schedule Pocket-size.

The full adult immunization schedule is available in a smaller, portable format and includes the adult immunization schedule by age group, medical and other indications, and footnotes.


Easy-to-read Version for Patients

Easy-to-read Version for Patients

Recommended Immunization for Adults (those 19 years and older)
English | Spanish


Interactive Tools

Interactive Tools

CDC Vaccine Schedules App

2016 Get the CDC Vaccine Schedules app for clinicians and other health care professionals for immediate access to CDC’s latest recommended immunization schedules and view childhood, adolescent, adult, and catch-up vaccine schedules and footnotes on your smartphone and tablet devices.

Free downloads are available from the iTunes App Store and Google Play.

Note: app version 4.0 (reflecting the 2017 schedule) is in development; watch for the new version in March. If you previously downloaded the tool, check that you have version 3.0.1 with 2016 schedules and footnotes.


What Vaccines Do You Need?

Adolescent and Adult Vaccine Quiz

Patients can use the Interactive Adolescent and Adult Vaccine Quiz, an online assessment tool, to get a list of vaccines they may need. Patients are instructed to discuss with their doctor or healthcare professional about these vaccines.

Español: Cuestionario breve sobre vacunas para adolescentes y adultos

Top of Page

Presentation Graphics

Download the adult immunization schedule as a PowerPoint presentation.


Immunization Recommendations

Summary of Recommendations for Adult Immunization.

Top of Page

Note: To order the Adult immunization schedule, go to CDC-INFO on Demand - Publications and pull down the menu for "Programs". Select "Immunization and Vaccines (Schedules and Booklets)" and click "Search".

Top